Pneumocystis jiroveci pneumonia prophylaxis during maintenance therapy influences methotrexate/6-mercaptopurine dosing but not event-free survival for childhood acute lymphoblastic leukemia

Mette Levinsen; Diana Shabaneh; Cathrine Bohnstedt; Arja Harila-Saari; Olafur G. Jonsson; Jukka Kanerva; Anna Lindblom; Bendik Lund; Elisabeth W. Andersen; Kjeld Schmiegelow; Nordic Soc Paediat Haematology & O

doi:10.1111/j.1600-0609.2011.01695.x

Pneumocystis jiroveci pneumonia prophylaxis during maintenance therapy influences methotrexate/6-mercaptopurine dosing but not event-free survival for childhood acute lymphoblastic leukemia

Mette Levinsen, Diana Shabaneh, Cathrine Bohnstedt, Arja Harila-Saari, Olafur G. Jonsson, Jukka Kanerva, Anna Lindblom, Bendik Lund, Elisabeth W. Andersen, Kjeld Schmiegelow, Nordic Soc Paediat Haematology & O

Tutkimustuotos: Artikkelijulkaisu › Artikkeli › Tieteellinen › vertaisarvioitu

Alkuperäiskieli	englanti
Lehti	European Journal of Haematology
Vuosikerta	88
Numero	1
Sivut	78-86
Sivumäärä	9
ISSN	0902-4441
DOI - pysyväislinkit	https://doi.org/10.1111/j.1600-0609.2011.01695.x
Tila	Julkaistu - 2012
OKM-julkaisutyyppi	A1 Alkuperäisartikkeli tieteellisessä aikakauslehdessä, vertaisarvioitu

Tieteenalat

3123 Naisten- ja lastentaudit

Pääsy asiakirjaan

10.1111/j.1600-0609.2011.01695.x

Siteeraa tätä

Levinsen, M., Shabaneh, D., Bohnstedt, C., Harila-Saari, A., Jonsson, O. G., Kanerva, J., Lindblom, A., Lund, B., Andersen, E. W., Schmiegelow, K., & Nordic Soc Paediat Haematology & O (2012). Pneumocystis jiroveci pneumonia prophylaxis during maintenance therapy influences methotrexate/6-mercaptopurine dosing but not event-free survival for childhood acute lymphoblastic leukemia. European Journal of Haematology, 88(1), 78-86. https://doi.org/10.1111/j.1600-0609.2011.01695.x

@article{59695f63f95f478cb1912d6237fb9b51,

title = "Pneumocystis jiroveci pneumonia prophylaxis during maintenance therapy influences methotrexate/6-mercaptopurine dosing but not event-free survival for childhood acute lymphoblastic leukemia",

keywords = "childhood acute lymphoblastic leukemia, treatment, infection, WHITE BLOOD-CELL, TRIMETHOPRIM-SULFAMETHOXAZOLE, PROGNOSTIC IMPORTANCE, DOSE INTENSITY, CHEMOTHERAPY, CHILDREN, RELAPSE, METHOTREXATE, RISK, MYELOSUPPRESSION, 3123 Gynaecology and paediatrics",

author = "Mette Levinsen and Diana Shabaneh and Cathrine Bohnstedt and Arja Harila-Saari and Jonsson, {Olafur G.} and Jukka Kanerva and Anna Lindblom and Bendik Lund and Andersen, {Elisabeth W.} and Kjeld Schmiegelow and {Nordic Soc Paediat Haematology & O}",

year = "2012",

doi = "10.1111/j.1600-0609.2011.01695.x",

language = "English",

volume = "88",

pages = "78--86",

journal = "European Journal of Haematology",

issn = "0902-4441",

publisher = "John Wiley and Sons Inc",

number = "1",

}

Levinsen, M, Shabaneh, D, Bohnstedt, C, Harila-Saari, A, Jonsson, OG, Kanerva, J, Lindblom, A, Lund, B, Andersen, EW, Schmiegelow, K & Nordic Soc Paediat Haematology & O 2012, 'Pneumocystis jiroveci pneumonia prophylaxis during maintenance therapy influences methotrexate/6-mercaptopurine dosing but not event-free survival for childhood acute lymphoblastic leukemia', European Journal of Haematology, Vuosikerta 88, Nro 1, Sivut 78-86. https://doi.org/10.1111/j.1600-0609.2011.01695.x

Pneumocystis jiroveci pneumonia prophylaxis during maintenance therapy influences methotrexate/6-mercaptopurine dosing but not event-free survival for childhood acute lymphoblastic leukemia. / Levinsen, Mette; Shabaneh, Diana; Bohnstedt, Cathrine et al.
julkaisussa: European Journal of Haematology, Vuosikerta 88, Nro 1, 2012, s. 78-86.

Tutkimustuotos: Artikkelijulkaisu › Artikkeli › Tieteellinen › vertaisarvioitu

TY - JOUR

T1 - Pneumocystis jiroveci pneumonia prophylaxis during maintenance therapy influences methotrexate/6-mercaptopurine dosing but not event-free survival for childhood acute lymphoblastic leukemia

AU - Levinsen, Mette

AU - Shabaneh, Diana

AU - Bohnstedt, Cathrine

AU - Harila-Saari, Arja

AU - Jonsson, Olafur G.

AU - Kanerva, Jukka

AU - Lindblom, Anna

AU - Lund, Bendik

AU - Andersen, Elisabeth W.

AU - Schmiegelow, Kjeld

AU - Nordic Soc Paediat Haematology & O

PY - 2012

Y1 - 2012

KW - childhood acute lymphoblastic leukemia

KW - treatment

KW - infection

KW - WHITE BLOOD-CELL

KW - TRIMETHOPRIM-SULFAMETHOXAZOLE

KW - PROGNOSTIC IMPORTANCE

KW - DOSE INTENSITY

KW - CHEMOTHERAPY

KW - CHILDREN

KW - RELAPSE

KW - METHOTREXATE

KW - RISK

KW - MYELOSUPPRESSION

KW - 3123 Gynaecology and paediatrics

U2 - 10.1111/j.1600-0609.2011.01695.x

DO - 10.1111/j.1600-0609.2011.01695.x

M3 - Article

SN - 0902-4441

VL - 88

SP - 78

EP - 86

JO - European Journal of Haematology

JF - European Journal of Haematology

IS - 1

ER -